Cell Counting Market Size To Reach $20.5 Billion By 2033

May 2026 | Report Format: Electronic (PDF)

Cell Counting Market Growth & Trends

The global cell counting market size is expected to reach USD 20.5 billion in 2033 and is projected to grow at a CAGR of 9.3% from 2026 to 2033, according to a new report by Grand View Research, Inc. Rising prevalence of chronic diseases such as cancer, HIV, and Alzheimer’s is the high impact rendering growth driver of the industry. Increasing prevalence of these diseases has surged clinical research activities, consequently propelling the demand for cell counting instruments and consumables. Government initiatives working to promote the development of cell therapeutics, wherein cell counting plays an imperative role, are also expanding growth prospects for the market.

An increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided a significant boost to growth. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate the generation of accurate results are likely to improve the adoption of instruments over the coming years. For instance, in May 2021, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve the quality of preclinical studies.

Technological advancements in these devices are also broadening growth prospects of the market. One of the promising technological advancements in differential cell counting is the ability to recognize blasts, immunoplatelet counting, detection of blasts, and reticulocyte fractions and stem cell counting with greater accuracy. The advent of CD4+ T-cell counting technology has proven to be very useful as an indicator of immune responses and has been adopted to evaluate the success or failure of Anti-retroviral Therapy (ARV). Dedicated cytometers are present in the market to perform CD4+ and CD8+ T-cell enumeration, such as the FACSCount by Becton Dickinson is based on T-cell counting technology.

The COVID-19 pandemic is anticipated to positively impact industry growth. WBC count of the COVID-19 patient during admission is significantly correlated with the death of patients. A higher level of white blood count should be given further care in the COVID-19 treatment. The growing importance of cell count in patients suffering from COVID-19 has augmented the growth of the industry during the pandemic.

The development of enhanced informatics solutions and improved image analysis instruments such as optical or fluorescence microscopes have fueled the growth prospects of this market. These instruments are being increasingly adopted in low sample throughput laboratories and settings with limited resources, which is highly prevalent in developing economies, thereby broadening the scope for growth of the industry.

On the other hand, limited availability of skilled professionals is the critical growth-restraining factor of the market. The lack of skilled professionals can be attributed to a lack of training facilities and high training costs. In order to improve this scenario, industry players are required to participate in the generation of training programs for software developed by these companies and encourage healthcare professionals and researchers to operate cell counting software. Moreover, the lack of standardization of these software tools also plays a key role in restricting researchers and healthcare professionals as every software differ in user interface.

key Request a free sample copy or view report summary: Cell Counting Market Report

Cell Counting Market Report Highlights

By product, consumables and accessories segment accounted for the largest revenue share of 54.2% in 2025. Their ongoing use in laboratories, especially in personalized medicine and biopharmaceutical research, drives consistent demand due to their role in quality control and standardizing procedures within the cell counting ecosystem.
By application, the complete blood count (CBC) segment held the largest share, 59.0%, in 2025, driven by its critical role in diagnosing and monitoring health conditions
In the end-use segment, research and academic institutes accounted for the largest revenue share of 39.8% in 2025 owing to growing number of government initiatives focused on promoting R&D in various toxicology studies

Cell Counting Market Segmentation

Grand View Research has segmented the global cell counting market report on the basis of product, application, end use, and region:

Cell Counting Product Outlook (Revenue, USD Million, 2021 - 2033)

Instruments
- Spectrophotometers
- Flow Cytometers
- Hemocytometer
- Automated Cell Counters
- Microscopes
- Others
Consumables & Accessories
- Reagents
- Microplates
- Others